9 Minute Read
We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
5 Minute Read
We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.
4 Minute Read
Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.
6 Minute Read
Market access leaders from DBV Technologies, Karyopharm Therapeutics, and Sesen Bio discuss critical factors in a successful launch and ways to achieve pre-launch forecasts.
3 Minute Read
We ask market access leaders what they would change if they had the ability to launch their therapy all over again.
3 Minute Read
Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices.
3 Minute Read
A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product.